Screener
Moderna MRNA Other Non-Current Liabilities
Other Non-Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Moderna in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.
The source filing: Moderna’s 8-K, filed July 31, 2026. Open the filing →
- Filed
- Jul 31, 2026, 7:03 AM EDT
- Accession
- 0001682852-26-000147
FAQ
- What is Moderna's other non-current liabilities?
- Moderna (MRNA) reported other non-current liabilities of $284M in Q2 2026.
- How has Moderna's other non-current liabilities changed year-over-year?
- Moderna's other non-current liabilities increased by 2.9% year-over-year, from $276M to $284M.
- What is the long-term trend for Moderna's other non-current liabilities?
- Over 5 years (2020 to 2025), Moderna's other non-current liabilities has grown at a 148.6% compound annual growth rate (CAGR), from $3M to $285M.
- What does other non-current liabilities mean?
- Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.
Ask your AI about Moderna's other non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude